Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells

Tissue Engineering - Part A

Volumn 20, Issue 19-20, 2014, Pages 2737-2745

  Abdeen, Amr A ^a   Weiss, Jared B ^a   Lee, Junmin ^a   Kilian, Kristopher A ^a  

^a University of Illinois at Urbana Champaign   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CELL CULTURE; ENDOTHELIAL CELLS; ENZYME INHIBITION; FLOWCHARTING; HYDROGELS; MUSCLE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEINS; RIGIDITY; STEM CELLS; STIFFNESS;

EXTRACELLULAR MATRICES; HUMAN MICROVASCULAR ENDOTHELIAL CELLS; INHERENT COMPLEXITY; MESENCHYMAL STEM CELL; MICROPATTERNED SURFACE; POLYACRYLAMIDE HYDROGELS; SMALL-MOLECULE INHIBITORS; THERAPEUTIC TREATMENTS;

CELL SIGNALING;

ANGIOGENESIS MODULATOR; COLLAGEN TYPE 1; FIBRONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; MYOSIN ADENOSINE TRIPHOSPHATASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN; CONDITIONED MEDIUM; HYDROGEL;

ANGIOGENESIS; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CAPILLARY ENDOTHELIAL CELL; CELL ADHESION; CELL SPREADING; CELLULAR SECRETION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; IMMUNOFLUORESCENCE TEST; MESENCHYMAL STEM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RIGIDITY; SIGNAL TRANSDUCTION; STEM CELL CULTURE; CHEMISTRY; CONDITIONED MEDIUM; CYTOLOGY; ENDOTHELIUM CELL; MECHANICAL STRESS; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY;

CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; HYDROGELS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; STRESS, MECHANICAL;

EID: 84911897046     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0661     Document Type: Article

References (41)

1. Finegold, J.A., Asaria, P., and Francis, D.P. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 168, 934, 2012.
2. Tabibiazar, R., and Rockson, S.G. Angiogenesis and the ischaemic heart. Eur Heart J 22, 903, 2001.
3. Zachary, I., and Morgan, R.D. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 97, 181, 2011.
4. Epstein, S.E., Kornowski, R., Fuchs, S., and Dvorak, H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115, 2001.
5. Beohar, N., Rapp, J., Pandya, S., and Losordo, D.W. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol 56, 1287, 2010.
6. Ranganath, S.H., Levy, O., Inamdar, M.S., and Karp, J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244, 2012.
7. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
8. Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
9. Da Silva, M.L., Caplan, A.I., and Nardi, N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287, 2008.
10. Ankrum, J., and Karp, J.M. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 16, 203, 2010.
11. Muscari, C., Bonafé, F., Carboni, M., Govoni, M., Stanic, I., Gamberini, C., et al. Difluoromethylornithine stimulates early cardiac commitment of mesenchymal stem cells in a model of mixed culture with cardiomyocytes. J Cell Biochem 103, 1046, 2008.
12. Wingate, K., Bonani, W., Tan, Y., Bryant, S.J., and Tan, W. Compressive elasticity of three-dimensional nanofiber matrix directs mesenchymal stem cell differentiation to vascular cells with endothelial or smooth muscle cell markers. Acta Biomater 8, 1440, 2012.
13. Lozito, T.P., Kuo, C.K., Taboas, J.M., and Tuan, R.S. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 107, 714, 2009.
14. Leiker, M. Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells. Cell Transplant 17, 911, 2008.
15. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
16. Ohnishi, S., Yasuda, T., Kitamura, S., and Nagaya, N. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25, 1166, 2007.
17. Afzal, M.R., Haider, H.K., Idris, N.M., Jiang, S., Ahmed, R.P.H., and Ashraf, M. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxid Redox Signal 12, 693, 2010.
18. Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., and Ashraf, M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77, 134, 2008.
19. Herrmann, J.L., Wang, Y., Abarbanell, A.M., Weil, B.R., Tan, J., and Meldrum, D.R. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock 33, 24, 2010.
20. Yang, F., Cho, S.-W., Son, S.M., Bogatyrev, S.R., Singh, D., Green, J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 107, 3317, 2010.
21. Engler, A.J., Sen, S., Sweeney, H.L., and Discher, D.E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677, 2006.
22. Kilian, K.A., Bugarija, B., Lahn, B.T., and Mrksich, M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA 107, 4872, 2010.
23. Rowlands, A.S., George, P.A., and Cooper-White, J.J. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol 295, 1037, 2008.
24. Zhang, D., and Kilian, K.A. The effect of mesenchymal stem cell shape on the maintenance of multipotency. Biomaterials 34, 3962, 2013.
25. Lee, J., Abdeen, A.A., Zhang, D., and Kilian, K.A. Directing stem cell fate on hydrogel substrates by controlling cell geometry, matrix mechanics and adhesion ligand composition. Biomaterials 34, 8140, 2013.
26. Kasper, G., Dankert, N., Tuischer, J., Hoeft, M., Gaber, T., Glaeser, J.D., et al. Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25, 903, 2007.
27. Seib, F.P., Prewitz, M., Werner, C., and Bornhaüser, M. Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). Biochem Biophys Res Commun 389, 663, 2009.
28. Rao, R.R., Peterson, A.W., Ceccarelli, J., Putnam, A.J., and Stegemann, J.P. Matrix composition regulates threedimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 15, 253, 2012.
29. Damljanovic, V., Christoffer Lagerholm, B., and Jacobson, K. Bulk and micropatterned conjugation of extracellular matrix proteins to characterized polyacrylamide substrates for cell mechanotransduction assays. Biotechniques 39, 847, 2005.
30. Hoffmann, C., Leroy-Dudal, J., Patel, S., Gallet, O., and Pauthe, E. Fluorescein isothiocyanate-labeled human plasma fibronectin in extracellular matrix remodeling. Anal Biochem 372, 62, 2008.
31. Tse, J.R., and Engler, A.J. Preparation of hydrogel substrates with tunable mechanical properties. Curr Protoc Cell Biol Chapter 10, Unit 10.16, 2010.
32. Tseng, Q., Wang, I., Duchemin-Pelletier, E., Azioune, A., Carpi, N., Gao, J., et al. A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels. Lab Chip 11, 2231, 2011.
33. Pelham, R., and Wang, Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA 94, 13661, 1997.
34. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., and Chen, C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6, 483, 2004.
35. Gilbert, P.M., Havenstrite, K.L., Magnusson, K.E.G., Sacco, A., Leonardi, N.A., Kraft, P., et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329, 1078, 2010.
36. Skalnikova, H., Motlik, J., Gadher, S.J., and Kovarova, H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 11, 691, 2011.
37. Samper, E., Diez-Juan, A., Montero, J.A., and Sepúlveda, P. Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 9, 266, 2013.
38. Huebsch, N., Arany, P.R., Mao, A.S., Shvartsman, D., Ali, O.A., Bencherif, S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stemcell fate. Nat Mater 9, 518, 2010.
39. Baker, B.M., and Chen, C.S. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125, 3015, 2012.
40. Fischbach, C., Kong, H.J., Hsiong, S.X., Evangelista, M.B., Yuen, W., and Mooney, D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 106, 399, 2009.
41. Aguado, B.A., Mulyasasmita, W., Su, J., Lampe, K.J., and Heilshorn, S.C. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A 18, 806, 2012.